Hypofractionated external beam radiation therapy and single fraction HDR-brachytherapy: Improving the results in the treatment of intermediate-risk prostate cancer

被引：0
|
作者：
Duclos, Marie
Aprikian, Armen G.
Cury, Favio
David, Marc
Shenouda, George
Steinberg, Jordan
Faria, Sergio
Bahoric, Boris
Patrocino, Horacio
Souhami, Luis
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)61164-7
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [31] HDR-Brachytherapy of localized prostate cancer -: Long term results in a single centre
    Stübinger, SH
    Van der Horst, C
    Erdt, O
    Overmoyer, K
    Braun, PM
    Juenemann, KP
    JOURNAL OF UROLOGY, 2006, 175 (04): : 216 - 216
  • [32] A TCP model for external beam treatment of intermediate-risk prostate cancer
    Walsh, Sean
    van der Putten, Wil
    MEDICAL PHYSICS, 2013, 40 (03)
  • [33] Phase I/II trial of HDR-brachytherapy boosted comprehensive IMRT for intermediate-risk adenocarcinoma of the prostate
    Hagan, M.
    Todor, D.
    Dogan, N.
    Wu, Y.
    Anscher, M.
    Arthur, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S363 - S363
  • [34] Combination External Beam Radiation and Brachytherapy Boost with Androgen Suppression for Treatment of Intermediate-risk Prostate Cancer: Long-term Results of CALGB 99809
    Hurwitz, M.
    Halabi, S.
    Archer, L.
    McGinnis, L. S.
    Kuettel, M. R.
    DiBiase, S. J.
    Small, E. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S146 - S146
  • [35] The Impact of Clinical Pathways on Adoption of Hypofractionated External Beam Radiation in Patients with Low- or Intermediate-Risk Prostate Cancer
    Patel, A. K.
    Ling, D. C.
    Smith, R. P.
    Heron, D. E.
    Beriwal, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E300 - E300
  • [36] Hormonal Therapy or External Beam Radiation with Brachytherapy and the Risk of Death from Prostate Cancer in Men with Intermediate Risk Prostate Cancer
    Rosenberg, J. E.
    Chen, M.
    Nguyen, P. L.
    Braccioforte, M. H.
    Moran, B. J.
    D'Amico, A. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S367 - S368
  • [37] External Beam Radiation Therapy With or Without Low Dose Rate Brachytherapy: Analysis of Favorable and Unfavorable Intermediate-Risk Prostate Cancer Patients
    Dess, R. T.
    Abugharib, A.
    Soni, P. D.
    Narayana, V.
    Evans, C.
    Gaber, M. S.
    Feng, F. Y.
    McLaughlin, P. W.
    Spratt, D. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E227 - E228
  • [38] High Dose Rate Brachytherapy With Hypofractionated External Beam Radiation Therapy for High-Risk Prostate Cancer
    Ishii, Y.
    Hashimoto, Y.
    Kono, S.
    Izumi, S.
    Iizuka, J.
    Karasawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E241 - E241
  • [39] Brachytherapy versus external-beam radiation therapy in patients with surgically staged, intermediate-risk endometrial cancer
    Amneus, M.
    Delic, L.
    Cass, I.
    Li, A. J.
    Leuchter, R.
    Karlan, B. Y.
    Walsh, C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S68 - S69
  • [40] Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: An initial report of CALGB 99809
    Hurwitz, Mark D.
    Halabi, Susan
    Ou, San-San
    McGinnis, Lamar S.
    Keuttel, Michael R.
    DiBiase, Steven J.
    Small, Eric J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (03): : 814 - 819
12345